Sézary syndrome patient–derived models allow drug selection for personalized therapy

Current therapeutic approaches for Sézary syndrome (SS) do not achieve a significant improvement in long-term survival of patients, and they are mainly focused on reducing blood tumor burden to improve quality of life. Eradication of SS is hindered by its genetic and molecular heterogeneity. Determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallardo, Fernando, Andrades, Evelyn, Iglesias, Arnau, González, Jessica, Solé, Laura, Guillén, Yolanda, Blanco, Gonzalo, Colomo, Luis, Gimeno, Eva, Conde, David, Rodriguez, Eva, Bielsa-Marso, Isabel, Iglesias, Mar, Bellosillo, Beatriz, Pujol, Ramon M., Regueiro, José R., Bigas, Anna, Espinosa, Lluís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198935/
https://www.ncbi.nlm.nih.gov/pubmed/35413113
http://dx.doi.org/10.1182/bloodadvances.2021006860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198935/
https://www.ncbi.nlm.nih.gov/pubmed/35413113
http://dx.doi.org/10.1182/bloodadvances.2021006860

Ejemplares similares